MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint® System
May 14 2019 - 10:13AM
Business Wire
MC10, Inc., a healthcare technology company specializing in
wearable digital health sensors, and AbbVie (NYSE: ABBV), a
research-based global biopharmaceutical company, announced today
that the companies are working together on clinical trials designed
to explore a range of outcome measures in patients with multiple
sclerosis (MS) using the BioStamp nPoint® system.
This innovative, patient-focused endeavor aims to explore the
use of data from the nPoint® System in order to provide unique
insights into MS clinical studies. “We are excited to work with a
world leader in CNS therapies and look forward to exploring novel
data and metrics that help to advance clinical development”
commented Dr Arthur Combs, Chief Medical Officer of MC10.
The 510(k) cleared BioStamp nPoint System was developed for use
in clinical trials and other applications for the continuous
collection of physiological data and is optimized for both in-home
and in-clinic use. The system reports vital signs, activity and
postural classifications and a suite of sleep metrics. The BioStamp
nPoint System is in use today by numerous pharmaceutical companies
and in academic research across several therapeutic areas.
“We are excited to explore the BioStamp nPoint System’s ability
to unobtrusively collect clinically relevant data continuously from
subjects in more natural settings. This technology has the
potential to improve the quality of data we collect and at the same
time reduce the burden on study participants,” commented Dr.
Michael Gold, Vice President, Development Neurosciences, of
AbbVie.
About MC10MC10 is a privately held company, backed by a
strong syndicate of financial and strategic investors, that is
improving human health through digital healthcare solutions. The
company combines its proprietary ultra-thin, flexible body-worn
sensors with advanced analytics to unlock health insights from
physiological data. MC10 is headquartered in Lexington, MA. Visit
MC10 online at https://www.mc10inc.com.
MC10®, BioStamp nPoint®, and the MC10 logo are registered marks
owned by MC10, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190514005133/en/
MC10, Inc.Katie Nolanknolan@mc10inc.com
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Aug 2024 to Sep 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Sep 2023 to Sep 2024